Search Results for "Inj Piperacillin Tazobactam Dose In Neonate"
Original Source: Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates
This is a phase I open label multi-dose study to investigate the pharmacokinetics and safety of piperacillin-tazobactam in infants < 61 days of age with suspected sepsis. There will be four cohorts of 8 infants each: 1. < 32 weeks gestational age and < 14 days postnatal age 2. < 32 weeks gestational age and >=14 days postnatatal age 3. >=32 weeks gestational age and < 14 days postnatal age 4. >=32 weeks gestational age and >=14 days postnatal age. The study re...
Matching Channels
Prior neonate with a genetic or congenital disorder
Thimerosal is a mercury-based preservative that has been used for decades in the United States in multi-dose vials (vials containing more than one dose) of some vaccines to prevent the growth of ger...
Kadcyla (ado-trastuzumab emtansine)
Kadcyla™ (ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have received prior treatment with Herceptin® (trastuzumab)...
Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...
Anthrax Vaccines and Therapeutics
Anthrax is a zoonotic disease caused by the spore-forming bacterium Bacillus anthracis. The disease most commonly occurs in mammals (e.g., cattle, sheep, goats, camels, antelope. Anthrax occurs in hu...
Matching News
Audience: Risk Manager, Nursing, Health Professional ISSUE: Apotex Corp. notified healthcare professionals it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall...
Apotex recalls Piperacillin, Tazobactam for injection USP 40.5 grams
Canada-based pharmaceutical company Apotex, on behalf of the manufacturer Hospira, has issued a voluntary recall of 15 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, in the US.
Apotex recalls 21 lots of Piperacillin, Tazobactam for Injection in US
Apotex, on behalf of Hospira, has initiated a US-wide voluntary recall of 21 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, over concerns that the recalled lots may show precipitat...
Fifteen Lots of Piperacillin/Tazobactam Recalled
The recalled product may show precipitation or crystallization after reconstitution, which may result in adverse events. News Alerts
Extended IV antibiotics may reduce mortality in severe infection
NEW YORK (Reuters Health) - Extended or continuous infusion of carbapenems and piperacillin/tazobactam may be associated with lower mortality rates, compared with short-term infusion, in some sett...
WESTON, FL, April 26, 2013 /PRNewswire/ - Apotex Corp. announced today that it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 15 lots of Piperacillin a...
WESTON, FL, May 10, 2013 /PRNewswire/ - Apotex Corp. announced today that it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 21 lots of Piperacillin and...
Matching PubMed Articles
BACKGROUND: Treating patients admitted to critical care with severe pneumonia requires timely intervention with an effective antibiotic. This reduces the risk of dying of pneumonia and minimises compl...
Rationale and evidence for extended infusion of piperacillin-tazobactam.
Purpose The pharmacodynamics and therapeutic effects of extended-infusion (EI) piperacillin-tazobactam therapy are reviewed, with an emphasis on growing evidence of its advantages over traditional inf...
Surveillance cultures may detect colonisation with drug-resistant Gram-negative bacteria and can be hypothesised to guide appropriate initial antibiotic treatment for intensive care unit (ICU) patient...
SUMMARYThere is concern that widespread usage of ertapenem may promote cross-resistance to other carbapenems. To analyse the impact that adding ertapenem to our hospital formulary had on usage of othe...
The purpose of this study is to compare the efficacy and safety of piperacillin/tazobactam (PIP/TAZO) versus PIP/TAZO plus amikacin in febrile neutropenic children with acute leukemia (AL). Children w...
